162 results on '"Osterlind K"'
Search Results
2. Prognostic Factors: From Clinical Parameters to New Biological Markers
3. Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy
4. Growth pattern of colorectal liver metastasis as a marker of recurrence risk
5. Two Subtypes of Therapy-Related Leukemia; Experience from The Copenhagen Series
6. Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy
7. Genomic alterations accompanying tumour evolution in colorectal cancer:tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing
8. Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients
9. Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
10. Growth pattern of colorectal liver metastasis as a marker of recurrence risk
11. Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy
12. 743P - Initial treatment and survival in a national unselected Danish cohort of 4161 patients with pancreatic cancer
13. Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples
14. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
15. A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease:Final results.
16. Quality of life of elderly persons with newly diagnosed cancer
17. Quality of life of elderly persons with newly diagnosed cancer.
18. PP068-SUN RANDOMIZED TRIAL OF THE EFFECTS OF INTENSIVE, INDIVIDUAL NUTRITIONAL COUNSELING IN CANCER PATIENTS
19. Early death during chemotherapy in patients with small-cell lung cancer:derivation of a prognostic index for toxic death and progression
20. Prognostic significance of EGFR FISH and IHC in non small-cell lung cancer patients treated with chemotherapy alone
21. Quality of life of elderly persons with newly diagnosed cancer
22. Outcome of combination chemotherapy in extensive stage small-cell lung cancer:any treatment related progress?
23. Discussion
24. 438 Increased pretreatment serum lactate dehydrogenase (LDH) is the most important determinant of central nervous system (CNS) metastases in patients with metastatic breast cancer
25. Chemotherapy in small cell lung cancer
26. Long-term survival in small-cell lung cancer:posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients
27. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
28. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
29. Long term survival in small cell lung cancer: Posttreatment characteristics in patients surviving five to 18 + years
30. Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC)
31. Quality of life of elderly persons with cancer: a 3-month follow-up.
32. Detection of bone marrow relapse in patients with small cell carcinoma of the lung.
33. Morphologic variations of small cell lung cancer. A histopathologic study of pretreatment and posttreatment specimens in 104 patients.
34. The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patients.
35. Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patients.
36. Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up.
37. Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patients
38. Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung
39. P-546 Phase I/II trial of patupilone once every 3 weeks in patients with non-small cell lung cancer (NSCLC)
40. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
41. LDH or NSE or LDH and NSE as pretreatment prognostic factors in small cell lung cancer?
42. The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients.
43. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.
44. Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients.
45. Exchange of 3-O-methylglucose in isolated fat cells. Concentration dependence and effect of insulin.
46. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer.
47. Cancer patients on the internet. Who surf? Why and where?
48. Paclitaxel, gemcitabin, and cisplatin in non-resectable non-small cell lung cancer (NSCLC)
49. Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up
50. The impact of abdominal computerized tomography on the pretreatment staging and prognosis of small cell lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.